Form 8-K - Current report:
SEC Accession No. 0001140361-22-026256
Filing Date
2022-07-18
Accepted
2022-07-18 16:15:50
Documents
14
Period of Report
2022-07-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10039761_8k.htm   iXBRL 8-K 27448
2 EXHIBIT 99.1 brhc10039761_ex99-1.htm EX-99.1 16822
6 image0.jpg GRAPHIC 85500
  Complete submission text file 0001140361-22-026256.txt   305500

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA axgn-20220712.xsd EX-101.SCH 3868
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE axgn-20220712_lab.xml EX-101.LAB 22546
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axgn-20220712_pre.xml EX-101.PRE 16046
8 EXTRACTED XBRL INSTANCE DOCUMENT brhc10039761_8k_htm.xml XML 4211
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Axogen, Inc. (Filer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36046 | Film No.: 221089332
SIC: 3845 Electromedical & Electrotherapeutic Apparatus